Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Alzheimer Disease

Women with Alzheimer’s have unusually low omega fatty acid levels, study finds

Analysis of blood samples finds women with the disease have 20% lower levels, a pattern not seen in men

The Guardian - UK

Cheap supplement may protect against Alzheimer’s in women

People can get omega fatty acids as a supplement or by eating salmon, mackerel or sardines.

Evening Standard

The mineral that could protect against Alzheimer’s disease

For nearly a decade, scientists from Harvard University have also been uncovering lithium’s unexpected importance in the brain

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

The vaccine that could lower the risk of dementia by 20 per cent

A new study could change the way we understand and treat dementia and other degenerative disorders of the brain

The Independent UK

Vaccines hold tantalizing promise in the fight against dementia

Over the past two centuries, vaccines have been critical for preventing infectious diseases. The World Health Organization estimates that vaccination prevents between 3 million and 5 million deaths annually from diseases like diphtheria, tetanus, influenza, measles and, more recently, COVID-19.

The Conversation

Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) heterozygotes or non-carriers.

Benzinga

Blood tests could reveal early signs of Alzheimer’s disease, research suggests

Researchers say the findings provide new insights into possible early indicators of Alzheimer’s disease

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Women are twice as likely to suffer from Alzheimer’s as men. Scientists have figured out why

One in three older Americans dies with Alzheimer's or another dementia

The Independent UK

High levels of Alzheimer‘s-linked protein found in healthy newborn babies

For years, scientists have assumed high levels of p-tau217 always spell trouble. The new research suggests they’ve been wrong

The Independent UK

Babies have more of this Alzheimer’s-linked protein than dementia patients – study raises hope for future treatments

A protein long blamed for the brain damage seen in Alzheimer’s disease has now been found in astonishingly high levels in healthy newborn babies, challenging decades of medical dogma.

The Conversation

Scientists Shocked to Find Alzheimer's Biomarker in Newborn Brains: A Groundbreaking Discovery Offering Hope for Early Intervention

Scientists have discovered an Alzheimer's biomarker in newborn brains for the first time. This breakthrough could lead to earlier detection and prevention of Alzheimer's disease.

International Business Times UK

Breast cancer survivors may have a lower risk of Alzheimer’s disease, experts say

South Korean researchers say they had found an 8 percent lower risk

The Independent UK

Gut bacteria may hold key to protecting brain against Alzheimers

A bacteria best known for causing stomach ulcers could lead to a new strategy in the fight against Alzheimer’s disease

The Independent UK

Breakthrough Alzheimer’s drugs rejected for use on the NHS. Here’s how they work

Scientists and doctors remain divided on the targeted antibody drugs that slow down the early stages of Alzheimer’s

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Alzheimer’s drugs rejected for NHS because benefits ‘too small’ to justify cost

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s.

The Independent UK

How a hated bacteria could protect the brain from Alzheimer’s disease

Helicobacter pylori – a bacteria best known for causing stomach ulcers – could lead to a new strategy in the fight against Alzheimer’s disease

The Conversation

Alzheimer’s: bacteria that causes stomach ulcers may protect the brain, our new research indicates

Every three seconds, someone in the world develops dementia. Alzheimer’s disease is the most common form of dementia, accounting for between 60% and 70% of all cases.

LiveScience

There's a new blood test for Alzheimer's. Here's everything you need to know about it.

In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests.

Get all your
news in one place.

100's of premium titles.
One news app.

Saving Advice

New Alzheimer’s Blood Test Leads To Early Detection And Treatment

A new Alzheimer’s blood test recently approved by the U. S. Food and Drug Administration (FDA) can now detect the disease in people with early...

The Independent UK

Blood test for Alzheimer’s could soon be available on the NHS

New study shows test is 95 per cent accurate in picking up people with memory problems

The Independent UK

Alzheimer’s blood test ‘can accurately pick up early symptoms’

Researchers found the blood test was 95% accurate in picking up people with the disease, with very few cases missed.

The Independent UK

Six crucial facts about Alzheimer’s and why there’s new hope for treatments

There was an 11% increase in Alzheimer’s disease clinical trials scheduled for 2025

Evening Standard

‘Hope on the horizon’ as drugs assessed for Alzheimer’s prevention

There has been an 11% increase in the number of clinical trials assessing potential treatments.

The Conversation

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease.

The Guardian - AU

Australia approves new drug to treat early Alzheimer’s disease

Kisunla is first new treatment registered by TGA in 25 years but could cost patients more than $80,000 and less than one in five will be eligible

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Alzheimer Research UK

152 stories

Harvard Medical School

the Alzheimer Society

51 stories

the Alzheimer Association

38 stories

The Therapeutic Goods Administration

25 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.